Medispan to market Biotec's TB detection kit

By Our Corporate Reporter

CHENNAI, AUG. 13. Biotec Laboratories, an established diagnostics company based in U.K., has entered into a tie-up with Medispan, promoted by the Chennai based Shriram group, to market the former's tuberculosis detection kits in India.

Addressing presspersons here today, Mr. Michael Hess, managing director, Biotec Laboratories, said `FAST plaque TB' - a product of biotechnology research - was a unique TB detection kit developed by the company based on Phage amplification technology.

With a maximum detection time of 48 hours against the 4-6 weeks for the conventional culture method, the kit has high specificity and is safe for lab staff.

The kit had undergone evaluation trials over two years in premier tuberculosis research institutes in India and approved by the Drug Controller General for marketing in India. He said Biotec's product range spanned seven groups and was sold through authorised dealer networks in over 40 countries.

Mr. R. S. Chari, managing director, Medispan, which manufactures and markets pharmaceutical formulations including anti- tuberculosis products throughout India, said the company would be working with microbiologists, diagnostic centres, hospitals and tuberculosis and chest disease specialists to achieve the national goal of eradication of tuberculosis.

Mr. R. Thiagarajan, chairman, Shriram group, said the group was promoting health care with the establishment of Medispan in Chennai and Medicorp Technologies in Hyderabad.

Send this article to Friends by E-Mail

Section  : Business
Previous : Future Software attains People CMM Level 3
Next     : Allsec Technologies to expand